Adverum Biotechnologies Gears Up for Key Investor Conferences
![Adverum Biotechnologies Gears Up for Key Investor Conferences](https://investorshangout.com/images/blog/ihnews-Adverum%20Biotechnologies%20Gears%20Up%20for%20Key%20Investor%20Conferences.jpg)
Adverum Biotechnologies Gears Up for Key Investor Conferences
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) is making headlines as it prepares to participate in several significant investor conferences aimed at showcasing its innovations and upcoming projects. This clinical-stage company is pioneering gene therapy to establish a new standard of care for prevalent ocular diseases.
Upcoming Conferences Overview
The company has announced its participation in notable events that will allow it to connect with investors and share its vision for the future. Specifically, these conferences include:
H.C. Wainwright 26th Annual Global Investment Conference
This key conference will take place on a Tuesday in mid-September, with Adverum scheduled to present at 3:30 p.m. ET. This event serves as a platform for the company to highlight its cutting-edge projects in gene therapy.
Chardan’s 8th Annual Genetic Medicines Conference
On the first day of October, Adverum Biotechnologies will take the stage at this important conference at 8:00 a.m. ET. This setting will further emphasize the company's advancements in genetic therapies.
UBS Virtual Ophthalmology Day
Shortly after the Chardan event, Adverum will be appearing at the UBS Virtual Ophthalmology Day on a Wednesday at 10:30 a.m. ET. As digital participation grows, this virtual format allows a broader audience to engage with Adverum's innovations.
Access to Webcasts
Investors and interested parties can tune in to the on-demand webcasts of these presentations via the Events and Presentations section on Adverum’s website. Each presentation will have a replay available for at least 30 days, ensuring that valuable insights can be revisited.
About Adverum Biotechnologies
Adverum Biotechnologies is dedicated to transforming the landscape of ocular disease treatment through innovative gene therapy. The company utilizes its proprietary intravitreal (IVT) platform to create one-time therapies that may alleviate the burden of frequent ocular injections. Their leading candidate, ixoberogene soroparvovec (Ixo-vec), is focused on treating conditions such as neovascular or wet age-related macular degeneration.
Beyond merely addressing current treatments, the company aims to redefine the standard of care, improving patients' quality of life and aiming for durable vision restoration.~ Adverum Biotechnologies is poised to create tangible societal impacts by overcoming the limitations of existing therapies in the ocular field.
Contact Information
For further inquiries, interested parties can reach out to Adverum's Investor Relations via email at ir@adverum.com.
Frequently Asked Questions
What is Adverum Biotechnologies focused on?
Adverum is committed to using gene therapy to combat prevalent ocular diseases, aiming to offer sustainable treatments for patients.
When will Adverum participate in investor conferences?
Adverum will present at multiple investor conferences in September and October, providing key updates on their advancements.
How can I access the investor presentations?
The presentations will be available on-demand on Adverum's website under the Events and Presentations section for at least 30 days after each event.
What is ixoberogene soroparvovec?
ixoberogene soroparvovec (Ixo-vec) is Adverum’s lead gene therapy candidate designed for the one-time treatment of wet age-related macular degeneration.
How does Adverum plan to address ocular diseases?
Adverum is focusing on developing durable therapies that enable patients to avoid repetitive injections, streamlining the treatment process and enhancing patient care.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Robinhood Settles for $3.9M Over Crypto Withdrawal Issues
- Investigation into iLearningEngines, Inc. Opens for AILE Investors
- Executives at ThredUp and Other Penny Stocks Are Investing
- Outset Medical Investors Face Critical Deadline Ahead of Lawsuit
- Splashtop Recognized as Strong Performer by Gartner Insights
- OHA Partners with Emergent BioSolutions for Debt Refinancing
- Innovative Eyewear Enhances Funding for Future Smart Glasses
- Technavio's Forecast: Optical Transceiver Market Growth Ahead
- Mexican Stock Market Up 0.43%: Key Insights and Highlights
- Airlines Ease A350 Checks Amid Safety Review Updates
- California Water Service Group Named Among World’s Most Trustworthy
- Water Softener Market Set for Growth as Awareness Increases
- Exploring Chronic Venous Insufficiency: Market Updates and Innovations
- Understanding BlackSky's 1-for-8 Reverse Stock Split Process
- Railway Maintenance Machinery Market Set for Major Growth
- Colombia Stock Market Update: COLCAP Declines by 0.87%
- Zions Bancorporation Set to Showcase at Upcoming Conference
- Ed Morse Automotive Group Expands with New Harley-Davidson Dealership
- Brazil's Senate Vote Set for Galipolo as Central Bank Chief
- Daktronics Growth and Strategic Investments for FY2025
- GitLab Forecasts Strong Revenue Growth for Q3 FY25
- Ripple President Enthusiastically Supports XRPL Advancements
- Globalink Investment Inc. Extends Deadline for Business Deal
- Descartes Systems Reports Strong Financial Results for Q2 FY25
- Forsys Metals Corp Welcomes Pierfranco Malpenga to Board
Recent Articles
- Vivani Medical Showcases Major Liver Fat Reduction Breakthrough
- The Expanding Contact Center Market Fueled by AI and Cloud Growth
- Water Softener Market Set for Growth as Awareness Increases
- Jordan Schur Backs Safety Shot with $3.4 Million Investment
- ONEflight International Welcomes New PGA Tour Ambassadors
- A Chance for Investors to Engage with SeaStar Medical's Case
- Collective Action Urged as Food Insecurity Rises Steadily
- Sportsman's Warehouse Reports Q2 Sales Dip, Highlights Strategy
- DBV Technologies' Engagement at H.C. Wainwright Conference
- Markel Appoints Jamie Mullarkey as Global Officer for Underwriting
- Cboe Global Markets to Showcase Innovations at Barclays Event
- Universal Health Realty Income Trust Declares Dividend Announcement
- BSI Financial's Gagan Sharma Receives 2024 Vanguard Award
- Customers Bancorp, Inc. Faces Securities Class Action Inquiry
- Verizon Targets Frontier Communications in Strategic Deal
- IMF Report Highlights Growth Potential in Saudi Economy
- 2024 Drive Electric Awards Honoring Leaders in EV Movement
- Laura O'Connor Earns HousingWire Vanguard Honor for 2024 Again
- CarMax Park Unveiled: A New Era for Richmond Flying Squirrels
- Subaru Reports 11.8% Sales Growth in August, Crosstrek Record
- Cargotec Corporation Announces Recent Share Repurchase Activity
- Hargreave Hale AIM VCT plc Announces Share Purchase Update
- SAS Recognized as Leader in AI and Machine Learning Platforms
- Trump Hotels Enhances Operations with BirchStreet's ReactorNet
- Industrial Cooling Systems Market Set for Remarkable Growth